On average, biomarker levels for patients with chronic liver disease fell between those in the fibrosis/cirrhosis and healthy groups, with a median GP73 concentration in the chronic liver disease group of 57.76 ng/mL and 12.75 pg/mL for LG2m (Fig. 1C, D). This evidence concerns the gene GOLM1 and Cirrhosis.